Guideline development for the treatment of patients with severe influenza who are critically ill
11 June, 2026
The Australian Living Evidence Collaboration is aware of the preliminary results recently released from the REMAP-CAP trial, with implications for the treatment of patients with influenza in critical care. In response, ALEC will be developing rapid, robust, evidence-based guidelines in consultation with relevant organisations, evidence specialists, people with lived experience and clinical experts. The trial, known as the Randomised, Embedded,...